ArticleFrontiers in nutrition2025
Global burden and temporal trends of tuberculosis attributable to high sugar-sweetened beverage consumption: insights from the Global Burden of Disease Study 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to assess the current global burden and temporal trends of tuberculosis (TB) attributable to high sugar-sweetened beverage (SSB) consumption, and to analyze its association with the Socio-demographic Index (SDI), in order to provide evidence for TB prevention and control strategies. Methods: Based on data from the Global Burden of Disease Study 2021 (GBD 2021), we analyzed changes in incidence, prevalence, disability-adjusted life years (DALYs), and mortality of TB attributable to high SSB consumption globally and across regions from 1990 to 2021. The Das Gupta decomposition method was applied to assess the contributions of population growth, aging, and epidemiological changes. Results: In 2021, global disability-adjusted life years (DALYs) and deaths due to TB attributable to high SSB consumption increased by 52 and 44%, respectively, compared to 1990. However, the age-standardized rates (per 100,000 population) declined. The burden was highest and grew most rapidly in low-middle SDI regions, while high SDI regions experienced the fastest decline in mortality rates. The disease burden peaked in the 50-54 age group and was higher in males than females. Cross-country inequality analysis indicated that the TB burden was more concentrated in lower SDI regions. Conclusion: The health burden of TB attributable to high SSB consumption presents complex global patterns. Low- and middle-income regions face higher TB risks, highlighting the need for strengthened public health measures, particularly interventions targeting high SSB consumption, to achieve the goal of ending the TB epidemic by 2030.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.